31 Mar 2024
Assets1,221.06
Total Income840.66
EBITDA185.09
Profit After Tax83.54
NET Worth807.94
Reserves and Surplus845.48
Total Borrowing174.58
At a glance
Updated 2026-08-24The shares listed at ₹980.00, a 21.44% move from the issue price. Molbio Diagnostics is a Mainboard IPO with an issue size of ₹939.70 crore, proposed for listing on BSE, NSE. The offer opens on 10th Aug 2026 and closes on 12th Aug 2026. The issue structure includes a fresh issue of ₹200.00 crore and an offer-for-sale component of ₹739.70 crore. The current listing schedule points to 17th Aug 2026.
Issue details
Listing atBSE, NSE
Issue typeBook Build Issue
Issue size₹939.70 Cr
Fresh issue₹200.00 Cr
Offer for sale₹739.70 Cr
Face value₹1
Price band₹768.00–₹807.00
Allotment13th Aug 2026
Listing17th Aug 2026
Listing performance
Full performance ↗Issue price₹807.00
Listing price₹980.00
Current price—
Listing gain21.44%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹116.00
GMP / upper price14.37%
Est. listing₹923.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens10th Aug 2026
Closes12th Aug 2026
Allotment13th Aug 2026
Refund14th Aug 2026
Demat14th Aug 2026
Listing17th Aug 2026
Subscription demand
Full bidding ↗Total70.27×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 18 | ₹14,526 |
| Retail (Max) | 13 | 234 | ₹188,838 |
| S-HNI (Min) | 14 | 252 | ₹203,364 |
| S-HNI (Max) | 68 | 1224 | ₹987,768 |
| B-HNI (Min) | 69 | 1242 | ₹1,002,294 |
Reservation
Issue mix
QIB49.91%58,12,862 shares
− Anchor Investor29.95%34,87,717 shares
− QIB (Ex. Anchor)19.96%23,25,145 shares
NII (HNI)14.97%17,43,860 shares
− bNII > ₹10L9.98%11,62,573 shares
− sNII < ₹10L4.99%5,81,287 shares
Retail34.94%40,69,005 shares
Preferential Reservations
Employee0.18%20,519 shares
Total100.00%1,16,46,246 shares
Company
Use of proceeds
| Object | Amount |
|---|---|
| Funding capital expenditure towards the setting up of infrastructure for research and development facility, Center of Excellence and connected office space. | ₹105.54 Cr |
| Funding capital expenditure towards the purchase of certain plant, machinery and other equipment for Goa Unit I, Goa Unit II and Visakhapatnam Unit, and | ₹72.28 Cr |
| General Corporate Purposes | ₹9.47 Cr |
| Issue Expenses | ₹59.54 Cr |
| Total | ₹246.83 Cr |
Financials
Full financials ↗31 Mar 2025
Assets1,461.56
Total Income1,027.94
EBITDA256.64
Profit After Tax138.58
NET Worth952.95
Reserves and Surplus990.84
Total Borrowing123.16
31 Mar 2026
Assets2,148.42
Total Income1,455.17
EBITDA328.24
Profit After Tax164.14
NET Worth1,144.68
Reserves and Surplus1,148.84
Total Borrowing412.64
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 | Mar 31, 2026 |
|---|---|---|
| ROE | 16.20% | 15.59% |
| ROCE | 20.98% | 17.55% |
| RoNW | 15.23% | 14.55% |
| PAT Margin | 13.48% | 11.28% |
| EBITDA Margin | 24.97% | 22.56% |
| Price to Book Value | 9.55 |
Valuation & shareholding
Pre-IPO EPS14.56
Post-IPO EPS14.24
Pre-IPO P/E55.43
Post-IPO P/E56.67
Promoter holding pre44.89%
Promoter holding post41.29%
Market cap₹9299.87 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Funding capital expenditure towards the setting up of infrastructure for research and development facility, Center of Excellence and connected office space. | ₹105.54 Cr |
| Funding capital expenditure towards the purchase of certain plant, machinery and other equipment for Goa Unit I, Goa Unit II and Visakhapatnam Unit, and | ₹72.28 Cr |
| General Corporate Purposes | ₹9.47 Cr |
| Issue Expenses | ₹59.54 Cr |
| Total | ₹246.83 Cr |
Registrar & lead managers
Registrar
Kfin Technologies Ltd.Lead managers
- Kotak Mahindra Capital Co.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.